Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy-Reference-Cited by-同舟云学术

Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapy

Published:2014-08-28 Issue:1 Volume:168 Page:94-101
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Karol Seth E.¹,Coustan-Smith Elaine²,Cao Xueyuan³,Shurtleff Sheila A.⁴,Raimondi Susana C.⁴⁵,Choi John K.⁴,Ribeiro Raul C.¹⁵,Dahl Gary V⁶,Bowman William Paul⁷,Taub Jeffrey W.⁸,Degar Barbara⁹,Leung Wing¹⁰,Downing James R.⁴,Pui Ching-Hon¹⁴⁵,Rubnitz Jeffrey E.¹⁵,Campana Dario²,Inaba Hiroto¹⁵

Affiliation:

1. Department of Oncology; St. Jude Children's Research Hospital; Memphis TN USA

2. Department of Paediatrics; National University of Singapore; Singapore Singapore

3. Department of Biostatistics; St. Jude Children's Research Hospital; Memphis TN USA

4. Department of Pathology; St. Jude Children's Research Hospital; Memphis TN USA

5. Department of Pediatrics; College of Medicine; University of Tennessee Health Science Center; Memphis TN USA

6. Division of Hematology/Oncology; Lucile Packard Children's Hospital and Stanford Cancer Center; Palo Alto CA USA

7. Division of Hematology/Oncology; Cook Children's Medical Center; Fort Worth TX USA

8. Division of Hematology/Oncology; Children's Hospital of Michigan; Detroit MI USA

9. Department of Pediatric Oncology; Dana-Farber Cancer Institute; Boston MA USA

10. Department of Bone Marrow Transplantation & Cellular Therapy; St. Jude Children's Research Hospital; Memphis TN USA

Funder

National Institutes of Health

American Lebanese Syrian Associated Charities

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13107/fullpdf

Reference32 articles.

1. Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate;Abrahamsson;Journal of Clinical Oncology,2011

2. Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group;Aplenc;Blood,2006

3. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study;Balgobind;Blood,2009

4. Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation;Bari;Journal of Clinical Oncology,2013

5. Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia;Buccisano;Blood,2012

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia;Blood Advances;2024-04-15

2. Measurable Residual Disease Assessment in Pediatric AML;Pediatric Oncology;2024

3. Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia;Blood Advances;2023-07-17

4. Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group;Journal of Clinical Oncology;2023-06-01

5. Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric de novo acute megakaryoblastic leukemia without Down syndrome in China: A single-center study;Frontiers in Oncology;2023-02-16